乳腺癌大分割放疗的急性毒性与生活质量
本文比较乳腺癌保乳术后全乳放疗大分割方案(4256 cGy/16次/22天)与常规方案(5000 cGy/25次/35天)的急性毒性和生活质量。急性毒性亚组161例,主试验1152例。大分割组在8周末皮肤急性毒性更低(P < .001),多个生活质量领域改善,主试验总体生活质量亦改善(均P < .01)。
要点
- 大分割全乳放疗较常规分割在8周末急性皮肤毒性更低(P < .001)。
- 大分割组在皮肤副作用、乳房副作用、疲劳、美观和便利性领域生活质量改善(均P < .05)。
- 主试验中大分割组总体生活质量及皮肤、乳房副作用和美观相关生活质量改善(均P < .01)。
核心结论
- 乳腺癌保乳术后大分割全乳放疗较常规分割急性毒性更低且生活质量改善。
研究设计与样本
- 随机对照试验,比较常规全乳放疗5000 cGy/25次/35天与大分割全乳放疗4256 cGy/16次/22天。
- 急性毒性亚组161例,主试验1152例。
主要发现
- 急性皮肤毒性初期两组相似,8周末大分割组更低(P < .001)。
- 治疗开始6周时大分割组在皮肤副作用、乳房副作用、疲劳、美观和便利性领域生活质量改善(均P < .05)。
- 主试验中大分割组总体生活质量及皮肤副作用、乳房副作用和美观相关生活质量改善(均P < .01)。
关键数值与推荐
- 常规全乳放疗剂量分割:5000 cGy分25次,35天完成。
- 大分割全乳放疗剂量分割:4256 cGy分16次,22天完成。
- 急性毒性亚组161例,主试验1152例。
临床怎么用
- 对于淋巴结阴性乳腺癌保乳术后全乳放疗,可考虑大分割方案以减少急性毒性并改善生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the acute toxicity and quality of life (QOL) of hypofractionation compared with conventional fractionation for whole breast irradiation (WBI) after breast-conserving surgery. METHODS AND MATERIALS: Women with node-negative breast cancer who had undergone breast-conserving surgery with clear margins were randomly assigned to conventional WBI of 5000 cGy in 25 fractions over 35 days or hypofractionated WBI of 4256 cGy in 16 fractions over 22 days. Acute skin toxicity and QOL were assessed at baseline and 2, 4, 6, and 8 weeks from the start of treatment for a subgroup of patients. QOL was assessed at baseline and 4 weeks posttreatment for all patients. In the acute toxicity substudy, repeated measures modeling was used to investigate treatment by time interactions over the 8-week period for acute toxicity and QOL mean change score. QOL mean change score from baseline to 4 weeks posttreatment was compared for all patients. RESULTS: In the acute toxicity substudy, 161 patients participated. In the main trial, 1152 patients participated. Acute skin toxicity was initially similar between groups but was less with hypofractionation compared with conventional fractionation toward the end of the 8-week period (P < .001). QOL at 6 weeks from the start of treatment was improved with hypofractionation for the skin side effects, breast side effects, fatigue, attractiveness, and convenience domains (all P < .05). In the main trial, hypofractionation resulted in improved overall QOL and QOL attributed to skin side effects, breast side effects, and attractiveness (all P < .01). CONCLUSIONS: Hypofractionated WBI compared with conventional WBI resulted in less acute toxicity and improved QOL. This further supports the benefits of hypofractionation.
引用
- Arsenault J, Parpia S, Goldberg M, et al. Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32334033. doi:10.1016/j.ijrobp.2020.03.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。